Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47,144,064
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12,180,657
-
Shares change
-
+1,083,865
-
Total reported value, excl. options
-
$294,157,682
-
Value change
-
+$23,865,901
-
Number of buys
-
26
-
Number of sells
-
10
-
Price
-
$24.15
Institutional Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q4 2021
As of 31 Dec 2021 Whitehawk Therapeutics, Inc. - Common stock (WHWK) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,180,657 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, ACUTA CAPITAL PARTNERS, LLC, VR Adviser, LLC, Vivo Capital, LLC, BVF INC/IL, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, and SATTER MANAGEMENT CO., L.P..
This table shows 49 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.